WCMNY
NUVB icon

Westchester Capital Management (New York)’s Nuvation Bio NUVB Stock Holding History

Westchester Capital Management (New York)’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-49,998
Closed -$560K – 241
2020
Q3 		$560K Buy
+49,998
New +$540K 0.02% 140

Other funds holding NUVB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

Westchester Capital Management (New York)'s NUVB Position: Q4 2020 in Review

Westchester Capital Management (New York) sold out of Nuvation Bio (NUVB) in Q4 2020, closing a stake of 49,998 shares — an estimated $560K sold.

Westchester Capital Management (New York) first reported a position in NUVB in Q3 2020 and held it in 1 quarter. The position peaked at $560K in Q3 2020. 33 funds tracked by Wall St. Rank hold NUVB as of Q4 2020.

  • Westchester Capital Management (New York) reported no remaining Nuvation Bio position as of Q4 2020 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 49,998 Nuvation Bio shares in Q4 2020, an estimated $560K.
  • Westchester Capital Management (New York) first reported a position in Nuvation Bio in Q3 2020 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Nuvation Bio position peaked at $560K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2020.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2020, filed 12 Feb 2021.